IVF Stock Analysis: Buy, Sell, or Hold?
IVF - INVO Fertility, Inc. Common Stock
$1.56
-0.01 (-0.95%)
βΌ
5d:
-14.29%
30d:
-29.41%
90d:
+50.0%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 19, 2026
3d
Get Alerted When IVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IVF this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: IVF is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: IVF is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IVF is currently trading at $1.56, which is considered oversold relative to its 30-day fair value range of $1.76 to $2.20.
Technical Outlook: Technically, IVF is in a uptrend. The price is currently testing key support at $1.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+1182.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IVF is in a uptrend. The price is currently testing key support at $1.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+1182.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.76 -
$2.20
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1182.1% below Wall St target ($20.00)
- WARNING: Recommendation downgraded due to -14.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.76 -
$2.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.55
Resistance Level
$2.02
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.07
Wall Street Target
$20.00
(+1182.1%)
Revenue Growth (YoY)
22.6%
Share & Embed Analysis
Last updated: May 14, 2026 7:19 PM ET
Data refreshes hourly during market hours. Next update: 8:19 PM
Data refreshes hourly during market hours. Next update: 8:19 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Matthew K Szot
SELL
2025-12-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |